Financial Year |
March 31 2023 |
Monetary Funds |
18,015,837,000.00 |
Held-for-trading Financial Assets |
2,598,000.00 |
Notes Receivable |
416,931,000.00 |
Accounts Receivable |
4,026,669,000.00 |
Advances to Suppliers |
2,976,847,000.00 |
Other Receivables |
1,659,894,000.00 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
27,871,182,000.00 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
827,284,000.00 |
Total Current Assets |
57,082,545,000.00 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
70,193,000.00 |
Long-term Equity Investment |
9,870,491,000.00 |
Investment Properties |
1,902,199,000.00 |
Fixed Assetes |
105,119,113,000.00 |
Under-construction Projects |
2,633,509,000.00 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
16,713,011,000.00 |
R&D expenses |
-- |
Goodwill |
3,494,894,000.00 |
Long-Term Deferred and Prepaid Expenses |
815,664,000.00 |
Deferred Income Tax Assets |
1,999,055,000.00 |
Other Non-Current Assets |
1,502,733,000.00 |
Sub-Total of Non-Current Assets |
155,865,400,000.00 |
Total Assets |
212,947,945,000.00 |
Short-Term Loans |
7,658,459,000.00 |
Trading Financial liabilities |
12,703,000.00 |
Notes Payable |
7,336,954,000.00 |
Accounts Payable |
15,835,276,000.00 |
Accounts Received In Advance |
105,839,000.00 |
Employee Compensation Payable |
768,895,000.00 |
Taxes Payable |
1,447,702,000.00 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
6,754,348,000.00 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
17,498,994,000.00 |
Other Current Liabilities |
454,573,000.00 |
Sub-Total of Current Liabilities |
60,813,224,000.00 |
Long-term Loans |
35,297,249,000.00 |
Bonds Payable |
13,336,424,000.00 |
Long-Term Accounts Payable |
669,002,000.00 |
Special Payable |
-- |
Estimatied Liabilities |
265,011,000.00 |
Deferred Income Tax Liabilities |
1,409,714,000.00 |
Other Non-Current Liabilities |
91,629,000.00 |
Sub-Total of Non-Current Liabilities |
61,315,480,000.00 |
Total Liabilities |
122,128,704,000.00 |
Paid-In Capital(Or Share Stock) |
17,161,592,000.00 |
Capital Surplus |
22,919,803,000.00 |
Surplus Reserve |
1,967,554,000.00 |
LESS:Treasury Stock |
404,685,000.00 |
Undistributed Profits |
11,995,565,000.00 |
Minority Stockholder's Interest |
34,440,907,000.00 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
56,378,334,000.00 |
Owner's Equity(Stockholder's Equity) |
90,819,241,000.00 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
212,947,945,000.00 |